 |
|
|
| |
Simplification to Single-Tablet Doravirine/Islatravir From Complex Antiretroviral
Regimens: Subgroup Analysis From a Randomized, Open-Label, Phase 3 Clinical Study
|
| |
| |
IAS 2026 Rio, Brazil
Jason Kim, MD, MSCE; Matthew G. Johnson, MD; Monica Fuszard, MS; Stephanie O. Klopfer, PhD;
Beth Jackson, BS; Tracy L. Diamond, PhD;
Ernest Asante-Appiah, PhD; Luisa M. Stamm, MD, PhD; Michelle C. Fox, MD*
Merck & Co., Inc., Rahway, NJ, USA
*Presenting author
|
| |
|
|
|
|
|
